{"id":"W2780749295","doi":"","title":"Hoge dosis imatinib versus hoge dosis imatinib in combinatie met intermediaire dosis cytarabine bij patienten met nieuw gediagnosticeerde chronische myeloïde leukemie","year":2014,"lang":"nl","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Imatinib; Cytarabine; Cancer research; Internal medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001236501,0.0003217974,0.001157461,0.0002648838,0.0003371414,0.001112852,0.0003958792,0.0006222628,0.01688832],"category_scores_gemma":[0.00250244,0.0002826594,0.0008837007,0.0003650846,0.0003832918,0.0009411859,0.0004440689,0.001785669,0.001252131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000615037,"about_ca_system_score_gemma":0.0007985945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001235551,"about_ca_topic_score_gemma":0.002700299,"domain_scores_codex":[0.9986041,0.0006842505,0.0001459835,0.0002311625,0.0002230339,0.0001114484],"domain_scores_gemma":[0.99909,0.0004259906,0.0001994651,0.00008899996,0.0000419171,0.0001536688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5039456,0.006262541,0.007373508,0.00226068,0.003190253,0.0001678159,0.0008823007,0.006009457,0.08919337,0.004218432,0.007415995,0.36908],"study_design_scores_gemma":[0.1695167,0.2843002,0.09958195,0.001574149,0.02355813,0.003268956,0.002633078,0.009538188,0.1506008,0.01569196,0.2392756,0.000460443],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9531654,0.02012988,0.003161108,0.002068326,0.001553574,0.0005723815,0.002071975,0.0001046094,0.01717273],"genre_scores_gemma":[0.983012,0.003086636,0.002868336,0.0004199949,0.0002135168,0.0005943319,0.0007360863,0.00006942574,0.008999671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01688832,"threshold_uncertainty_score":0.05649704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02164788474816356,"score_gpt":0.2734349102038177,"score_spread":0.2517870254556541,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}